AS

Avani Shrikant Joshi

Active Director Designated Partner DIN 11441363
DIN 11441363 First appointment Dec 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Avani Shrikant Joshi

Data last updated:

Avani Shrikant Joshi is a Designated Partner at Infogene Life Sciences Llp (since 2025).

DIN 11441363
Primary Designation Designated Partner
First Appointment 20 Dec 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner20 Dec 20252025Active

Board colleagues of Avani Shrikant Joshi

NameDINCompanyDesignation
Shrikant Vishwanath Joshi08428755Infogene Life Sciences LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Infogene Life Sciences Llp
Premium access

Shareholding and investment profile for Avani Shrikant Joshi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Avani Shrikant Joshi

Avani Shrikant Joshi currently holds 1 directorship: Infogene Life Sciences Llp (Designated Partner, since 20 Dec 2025).

Avani Shrikant Joshi was first appointed on 20 Dec 2025 as Designated Partner at Infogene Life Sciences Llp.

The current boards of Avani Shrikant Joshi's companies include Shrikant Vishwanath Joshi (Infogene Life Sciences Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available